MedPath

Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects

Phase 3
Completed
Conditions
Surgery
Interventions
Other: Vehicle
Drug: DynaHex-2
Registration Number
NCT02222896
Lead Sponsor
Medline Industries
Brief Summary

Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.

Detailed Description

Examine the antimicrobial cloth effects on normal flora bacteria of the abdomen and groin areas post CHG application.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
347
Inclusion Criteria
  • Males or Females
  • 16 years of age or older
  • Signed informed consent
  • Good Health
  • Six inches of abdomen and groin areas without tattoos, or skin disorders
Exclusion Criteria
  • Dermatological Conditions
  • Sensitivity to latex
  • Sensitivity to CHG

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vehicle ClothVehicleExcipients on cloth
Active Chlorhexidine gluconate solutionDynaHex-2Dynahex 2% CHG
Chlorhexidine Gluconate ClothChlorhexidine Gluconate2% CHG, single application
Primary Outcome Measures
NameTimeMethod
Percent Responder Rates (%) of Bacterial Reduction on the Abdomen and Groin10 minutes, 6 hours, 8 hours

Percent of abdomen and groin sites that showed response (achieve a 2-Log and 3-Log reduction) respectively of bacterial flora from baseline.

Note: the number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MBT

🇺🇸

Sterling, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath